It is a brand new year! It’s safe to say that the removal of the mandatory mask mandate should be the next big step Singaporeans will be all too eager to take on the road towards normalcy.
Yet in an interesting twist, it’s been observed that an overwhelming 93% of Singaporeans still supported the wearing of masks indoors. In fact, even as recently as the beginning of the month, the majority of Singaporeans still opted to shield their faces despite the relaxation of the mask-wearing mandate outdoors. The reason? Many feel that wearing a mask actually boosts their appearance – as similarly suggested by a study done in the UK, which concluded that women found men more attractive with their masks on. So severe is the present “mask-fishing” endemic that people have reportedly grown more self-conscious and increasingly anxious over the need to bare their face – and therefore expose their skin insecurities and perceived appearance flaws – after 2 long years of hiding behind a mask.
Enter Regenosis, a team of medical professionals that seek to innovate and reform the way beauty and health are viewed and treated in the world. Backed by a large panel of established doctors, dieticians and scientists, Regenosis seeks to renew one’s faith and confidence in themselves by addressing the underlying damages that are accumulated over time in their body through holistic and highly-personal rejuvenation programmes. From utilising cutting-edge medtech like DNA sequencing to fully customise a health and beauty routine for each client down to the molecular level, to more “low-fi” programmes like doctor-guided dietary and fitness regimes, Regenosis seeks to influence the external factors that cause skin ageing, physical blemishes and ill-health, to achieve a wholly natural look that predates one’s true age.
Together with their Chief Scientific Officer, Professor Brian Kennedy, a Professor in the Departments of Biochemistry and Physiology at NUS and Director of the Centre for Healthy Longevity in NUHS, Regenosis co-discovered and created Rejuvant LifeTabs at Buck Institute for Research on Aging.
Rejuvant LifeTabs help rejuvenate one’s body and maintain vitality by introducing Alpha-Ketoglutarate (AKG) into their diet, which extends lifespan and prolongs one’s healthiest years by retarding age-related disease (Wu et al., 2016). Due to its use of Calcium-AKG, Rejuvant LifeTabs is the only health supplement in the world to be clinically proven to reverse biological age by 7 to 8 years (Demidenko et al., 2021). Rejuvant LifeTabs has been shown to provide more energy, better sleep, weight loss, bodybuilding effects, and more youthful skin for its consumers.
Rejuvant LifeTabs does not exclusively cater to the elderly but rather to anyone who is looking to live life healthily – akin to the prime of the youth – by boosting vitality and preventing age-related diseases from internal ailments to skin woes, which could plague more than just one’s physical well-being, but their mental health as well.
Regenosis believes that every individual deserves to savour life in health, be it in their prime or at retirement. Through the principles of Geroscience Biotechnology, Regenosis’ extensive team of doctors, dieticians and scientists customise holistic and highly-personal programmes for their clients to help alleviate – even reverse – the effects of ageing, by restoring and repairing underlying damages that are accumulated over time in our bodies. Regenosis represents change, to innovate and reform the way diseases and ailments are viewed and treated in the world.
About Dr. Teo Cheng Peng
Co-founder of Regenosis
Medical Director, Haematology MBBS (Singapore), M.Med (Internal Medicine), FAMS (Haematology)
Dr Teo obtained his medical degree in NUS, post-grad qualification in 1984 and started his specialist training in haematology-oncology at NUS 1987. He then underwent further specialist training in stem cell therapy at Royal Marsden Hospital, UK.
He initiated and developed the Autologous Stem Cell Transplant programme at the Division of Haematology-Oncology, NUH and Department of Medical Oncology, SGH and was awarded another major grant by National Medical Research Council. With his interest in stem cell biology, he co-founded StemCord, the first private cord blood and stem cell bank in Singapore and achieved accreditation with the Foundation for Accreditation of Cellular Therapy (FACT), the most prestigious stem cell accreditation.
Along with his 30 years of clinical experience with NUH, SGH, Gleneagles Hospital, Dr Teo spearheaded the development of Stem Med, which specialises in Haemopoietic & MSC applications & Advance Cellular Therapy for Cancers. He also started the first MSC trial in liver cirrhosis in Singapore.
Currently, he is still active in his clinical practice in Parkway Cancer Centre and TalkMed Group and sits in the blood transfusion committees of both Gleneagles Hospital and Mt Alvernia Hospital. He also serves in the Medical Advisory Board of Mt Alvernia Hospital since 2000 and is a member of
Singapore Society of Haematology, Singapore Society of Oncology, International Society for Cellular Therapy. He is also a Fellow at the Academy of Medicine (Singapore).
About Prof. Brian Kennedy
Chief Scientific Officer
Prof Brian Kennedy graduated from the Northwestern University with Bachelors in Mathematics and BMBCB (Biochemistry, Molecular Biology and Cellular Biology) in 1989. He then attained his Ph.D. in Biology, from Massachusetts Institute of Technology (MIT).
Prof Kennedy is internationally recognised for his research in the biology of ageing and as a visionary committed to translating research discoveries into new ways of delaying, detecting, and preventing human ageing and associated diseases. He is a Professor in the Department of Biochemistry and Physiology at the National University Singapore and Director of the Centre for Healthy Longevity in the National University Health System.
From 2010 to 2016, he was the President and CEO of the Buck Institute for Research on Aging.
Currently, he remains a Professor at the Institute. Prof Kennedy also has an adjunct appointment at the USC Davis School of Gerontology and is a Fellow at the Gerontological Society of America, amongst other awards and appointments. He is also actively involved in Biotechnology companies, serving in consulting and Board capacities, as well as Scientific Director of Affirmative Health. Prof Kennedy also serves as a Co-Editor-In-Chief at Aging Cell, a peer-reviewed scientific journal and an official journal of the Anatomical Society.